4-butyrolactone has been researched along with Giant Osteoid Osteoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, X; Hu, L; Li, B; Li, J; Liu, Y; Wu, D; Xie, B; Zhang, B; Zheng, L | 1 |
1 other study(ies) available for 4-butyrolactone and Giant Osteoid Osteoma
| Article | Year |
|---|---|
Ligustilide inhibits the proliferation of human osteoblastoma MG63 cells through the TLR4-ERK pathway.
Topics: 4-Butyrolactone; Apoptosis; Bone Neoplasms; Caspases; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Osteoblastoma; Toll-Like Receptor 4; Tumor Cells, Cultured | 2022 |